Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients: Association with B-Cell Markers

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.14, Iss.1, 2010-02, pp. : 43-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients

By Ruyssen-Witrand Adeline

British Journal of Rheumatology , Vol. 52, Iss. 4, 2013-04 ,pp. : 636-641

Oxford University Press

Access to resources Recommend Favorite

Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus

By Reddy Venkat

British Journal of Rheumatology , Vol. 52, Iss. 5, 2013-05 ,pp. : 951-952

Oxford University Press

Access to resources Recommend Favorite

An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 4, 2015-04 ,pp. : 777-782

John Wiley & Sons Inc

Access to resources Recommend Favorite

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 8, 2015-05 ,pp. : 2046-2055

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate‐associated large B lymphoproliferative disorders

HISTOPATHOLOGY, Vol. 67, Iss. 1, 2015-07 ,pp. : 70-80

John Wiley & Sons Inc

Access to resources Recommend Favorite